PhD, University of Cincinnati, 2021, Medicine: Molecular Genetics, Biochemistry, and Microbiology
The transforming growth factor beta (TGFß) family consists of over 30 dimeric ligands that play distinct roles throughout biology, from development to homeostasis. These processes include wound-healing, reproductive health, adipogenesis, muscle and cardiac maintenance, and bone growth, among others. Three classes of TGFß have emerged: the TGFßs, the activins and the bone morphogenetic proteins (BMPs), separated based on sequence identity, receptor binding repertoires and biological functions. To signal, each ligand forms a hexameric complex with four receptors: two of the type II variant, of which there are five available, and 2 of the type I variant, of which there are seven available. The ratio of ligands to signaling receptors creates a receptor utilization bottleneck, where key differences in each ligand/receptor generate specificity and dictate interaction partners. In addition, different mechanisms of receptor assembly have emerged for the TGFß and BMP classes, where the positional assembly of ligand/receptor complex differs fundamentally. However, prior to our work, little structural information existed characterizing activin/receptor interactions, particularly for the type I receptor. Here, we present both biochemical and structural studies extending our understanding of the activin class. We have solved 4 unique structures within the activin class: 1) the structure of apo-GDF11, 2) the structure of GDF11 in complex with ActRIIB and Alk5, 3) the structure of GDF11 in complex with an ActRIIB-Alk4 fusion, and 4) the structure of ActA in complex with the ActRIIB-Alk4 fusion. Through this work, we presented the first structure of an activin class member bound by both the cognate type II and type I receptors, which bind independently. A composite interface is built from surfaces on both ligand monomers, where the majority of receptor ß4ß5 loop is engaged and a conserved knob-in-hole moiety is used to anchor the binding. Furthermore, through these studies, we have (open full item for complete abstract)
Committee: Thomas Thompson Ph.D. (Committee Chair); Andrew Herr Ph.D. (Committee Member); Rhett Kovall Ph.D. (Committee Member); John Monaco Ph.D. (Committee Member); Aaron Zorn Ph.D. (Committee Member)
Subjects: Biochemistry